BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
5.57
-0.09 (-1.59%)
At close: Aug 8, 2025, 4:00 PM
5.48
-0.09 (-1.62%)
After-hours: Aug 8, 2025, 4:43 PM EDT
BioNexus Gene Lab Market Cap
BioNexus Gene Lab has a market cap or net worth of $10.03 million as of August 8, 2025. Its market cap has increased by 14.61% in one year.
Market Cap
10.03M
Enterprise Value
6.65M
1-Year Change
14.61%
Ranking
Category
Stock Price
$5.57
Market Cap Chart
Since September 16, 2020, BioNexus Gene Lab's market cap has decreased from $42.12M to $10.03M, a decrease of -76.20%. That is a compound annual growth rate of -25.42%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 7, 2025 | 10.17M | 102.34% |
Dec 31, 2024 | 5.03M | -46.33% |
Dec 29, 2023 | 9.36M | -94.33% |
Dec 30, 2022 | 165.03M | -54.75% |
Dec 31, 2021 | 364.69M | 54.35% |
Dec 31, 2020 | 236.28M | 460.98% |
Sep 16, 2020 | 42.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Linde | 221.08B |
BHP Group | 131.64B |
Rio Tinto Group | 102.58B |
The Sherwin-Williams Company | 87.20B |
Southern Copper | 76.44B |
Ecolab | 76.21B |
Newmont | 74.58B |
Agnico Eagle Mines | 68.03B |